Schedule 13D ownership disclosure

Zomedica Pharmaceuticals Corp.

Security class unavailable · CUSIP: 98979F107

Event date: 2020-05-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,918,913
Percent of class
2.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-20-014549
Form type
SC 13D/A
Filer
EQUIDEBT LLC
CIK
CIK 1753306
Filed
Jul 02, 2020
Reporting period
May 27, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub